The cytoplasmic domain of the interleukin-1 receptor is required for nuclear factor-kappa B signal transduction

J Biol Chem. 1994 Jan 21;269(3):1579-82.

Abstract

Interleukin-1 (IL-1) plays a central role in mediating immune and inflammatory responses. Binding of IL-1 to the type I 80-kDa receptor results in generation of intracellular signals and activation of the transcription factor NF-kappa B. However, the nature of the signals required to generate NF-kappa B binding activity remains unclear. In this paper, we show that NF-kappa B1 (p50) and RelA (p65) were specifically translocated to the nucleus following activation of intact type I IL-1 receptor (IL-1R). The C-terminal region of the type I IL-1R is required for this effect, and deletion of its cytoplasmic domain abrogates the activation of NF-kappa B by IL-1. These results provide evidence that IL-1 modulates the activity of NF-kappa B through the type I IL-1 receptor and identifies a domain required for signal transduction to this specific transcription factor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Binding Sites
  • Cell Line
  • Cell Nucleus / metabolism*
  • Cytoplasm / metabolism
  • Gene Expression
  • Humans
  • Interleukin-1 / pharmacology*
  • Leukemia, T-Cell
  • Molecular Sequence Data
  • NF-kappa B / biosynthesis
  • NF-kappa B / isolation & purification
  • NF-kappa B / metabolism*
  • Oligodeoxyribonucleotides
  • Receptors, Interleukin-1 / biosynthesis
  • Receptors, Interleukin-1 / metabolism*
  • Restriction Mapping
  • Sequence Deletion
  • Signal Transduction*
  • Transcription Factor RelA
  • Transfection
  • Tumor Cells, Cultured

Substances

  • Interleukin-1
  • NF-kappa B
  • Oligodeoxyribonucleotides
  • Receptors, Interleukin-1
  • Transcription Factor RelA